Apollo Hospitals Enterprise Ltd Share Price Today - Apollo Hospitals Enterprise Ltd Stock Price Live NSE/BSE

Apollo Hospitals Enterprise Ltd

NSE: APOLLOHOSP BSE: 508869

₹7364.50

(1.55%)

Sat, 28 Mar 2026, 07:29 am

MTF 5xInvest in Apollo Hospitals Enterprise Ltd with 5x Leverage Buy with MTF

Market Cap1058.72B

PE Ratio58.77

Dividend0.27

Health Services

Hospital/Nursing Management

24.5K

Apollo Hospitals Enterprise Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
108534.41
Net Profit
1505.10
P/B
11.61
Sector P/E
54.52
P/E
65.86
EV/EBITDA
30.50
Debt/Equity (Industry)
0.48
Interest Cover (Industry)
7.37
ROCE (Industry)
16.81
RONW (Industry)
18.56
ROE
19.89
ROCE
17.49
Debt/Equity
0.61
EPS (TTM)
126.33
Dividend Yield
0.17
Book Value
631.88
Interest Cover
5.45

Analysis

all

Pros

Dividends per share have increased over the past 10 years.
Dividends paid are well covered by earnings (3.8x coverage).
Dividends after 3 years are expected to be well covered by earnings (4.5x coverage).
Dividends per share have been stable in the past 10 years.
Apollo Hospitals Enterprise's earnings are expected to grow significantly at over 20% yearly.

Cons

Apollo Hospitals Enterprise's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
Apollo Hospitals Enterprise's dividend is below the markets top 25% of dividend payers in India (3.08%).
Cash flow for Apollo Hospitals Enterprise is expected to increase but not above the 50% threshold in 2 years time.
Apollo Hospitals Enterprise's earnings are expected to increase but not above the low risk growth rate next year.
Apollo Hospitals Enterprise is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	28.02	28.02	29.34	29.34	29.33
FII	43.54	44.20	43.49	42.74	45.27
DII	21.51	21.12	21.34	22.29	19.98
Public	6.71	6.43	5.61	5.41	5.19
Government	0.23	0.23	0.23	0.23	0.23

Technical Analysis

RSI

52.11

MACD

-15.04

50 DMA

7375.44

200 DMA

7428.85

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	9586.67	8547.17	8184.33	7507.67	7144.83	6468.17	5428.67
Fibonacci	8547.17	8150.08	7904.76	7507.67	7110.58	6865.26	6468.17
Camarilla	8107.36	8012.07	7916.79	7507.67	7726.21	7630.93	7535.64

Pivots Level: Classic

+2079.00

9586.67

+1039.50

8547.17

+676.67

8184.33

7507.67

Pivot Point

LTP: 7549

-362.83

7144.83

-1039.50

6468.17

-2079

5428.67

Moving Average

SMAEMA

Period

Value

10-EMA
7473.60
20-EMA
7503.45
30-EMA
7490.62
50-EMA
7446.76
100-EMA
7401.27
200-EMA
7322.11

Announcement Date	Purpose	Action	Ex Date
10 Feb 2026	board-meetings	Quarterly Results
10 Feb 2026	dividend	₹10.00 Dividend /Share	16 Feb 2026
16 Jan 2026	dividend	Interim Dividend - Rs. - 10	16 Feb 2026
06 Nov 2025	board-meetings	Quarterly Results, Half Yearly Results
19 Jul 2025	dividend	Final Dividend - Rs. - 10	19 Aug 2025
30 May 2025	dividend	₹10.00 Dividend /Share	19 Aug 2025
30 May 2025	agm
10 Feb 2025	dividend	₹9.00 Dividend /Share	15 Feb 2025
15 Jan 2025	dividend	Interim Dividend - Rs. - 9	15 Feb 2025
14 Jan 2025	dividend	Interim Dividend - Rs 9 Per Share	15 Feb 2025

Apollo Hospitals Enterprise Ltd

Aster DM Healthcare Ltd

Max Healthcare Institute Ltd

Narayana Hrudayalaya Ltd

Fortis Healthcare Ltd

Global Health Ltd

Apollo Hospitals Enterprise Ltd About

Apollo Hospitals Enterprise The main business of the Company and its subsidiaries (hereinafter referred to as ‘the Group’) is to enhance the quality of life of patients by providing comprehensive, high-quality hospital services on a cost-effective basis and providing / selling high quality pharma and wellness products through a network of pharmacies, including operation of multidisciplinary private hospitals, clinics,diagonostic centers and pharmacies.

Industry

Healthcare

Founded

1979

Headquarters

CEO

Preetha Reddy

Employees

Contact

Website

http://www.apollohospitals.com

investor.relations@apollohospitals.com

Phone

91-44-28290956/28293896

Location

No 19 Bishop Garden, Raja Annamalaipuram, Chennai, Tamil Nadu, 600028

Year	History
2020	Launched Sanjeevani Telehealth Seva for non-COVID patients in Bhopal.
2021	Partnered with Anatomiz3D to establish 3D printing labs across several facilities.
2022	Partnered with Balmer Healthcare to set up tertiary care hospital in Kenya. Launched automated AI-based real-time rapid-response patient monitoring system, Enhanced Connected Care. Performed novel interventional procedures to save four patients with Atrial Fibrillation at Chennai. Performed world's first Endoscopic Transcanal Excision of Facial Nerve Schwannoma at Apollo Cancer Centre, Bangalore.
2023	Approved detailed expansion plan involving capital outlay of Rs. 34,350 million.
2024	Launched Fatty Liver Clinic at Chennai with cutting-edge diagnostic tools and pharmacological treatments. Apollo Proton Cancer Centre trained international doctors for Proton Beam Therapy in collaboration with Belgium-based IBA. Apollo Proton Cancer Centre unveiled India's first integrated organ and disease-specific programme for rectal cancer management. Apollo Cancer Centres launched Unmask Cancer initiative to tackle societal biases against cancer patients and survivors. Apollo Cancer Centre introduced India's fastest and most precise breast cancer diagnosis program.

Client Name	Order Side	QTY	Avg Price	Date
SUNEETHA REDDY	Sell	1897239	7850	22 Aug 2025
INTEGRATED CORE STRATEGIES (ASIA) PTE. LTD.	Sell	1883658	2344.89	27 Nov 2020
BNP PARIBAS ARBITRAGE	Buy	310	2349.21	27 Nov 2020
BNP PARIBAS ARBITRAGE	Sell	807914	2343.42	27 Nov 2020
MUNCHENER RUCKVERSICHERUNGS-GESELLSCHAFT AKTIENGESELLSCHAFT IN MUNCHEN	Sell	2397380	1600.43	03 Aug 2020
BIRLA MUTUAL FUND	Buy	700000	1352.16	13 Dec 2019
ABU DHABI INVESTMENT AUTHORITY - BEHAVE	Buy	965000	1482.5	12 Sept 2019
SOCIETE GENERALE	Buy	1358000	1482.5	12 Sept 2019
SUNEETA REDDY	Sell	5000000	1482.5	12 Sept 2019
OPPENHEIMER FUNDS INC	Sell	1400178	1044.23	26 Sept 2018

Apollo Hospitals Enterprise Ltd News

CITI Adds Apollo Hospitals to Pan-Asia Focus List

CITI issues Buy rating for Apollo Hospitals with Rs 9600 target price, citing resilient hospital business, fast-growing pharmacy operations, and attractive valuations below long-term averages.

24 Mar 2026

investment-ideas

Apollo Hospitals Completes AHLL Stake Acquisition

Apollo Hospitals Enterprise Limited has completed the acquisition of 30.58% equity stake in Apollo Health and Lifestyle Limited for Rs. 12,540.68 million, increasing its shareholding to 99.42%.

23 Mar 2026

companies

Apollo Hospitals Block Trade Worth Rs. 26.56 Crores

Apollo Hospitals Enterprise Ltd. witnessed a significant NSE block trade worth Rs. 26.56 crores involving approximately 35,043 shares at Rs. 7580.00 per share, indicating institutional investor activity.

18 Mar 2026

equity-markets

BofA Maintains Buy on Apollo Hospitals at ₹9,600

BofA Securities maintains Buy rating on Apollo Hospitals with ₹9,600 target price, citing 25%+ upside from margin expansion, digital growth, and potential HealthCo re-rating.

16 Mar 2026

investment-ideas

Apollo Hospitals Subsidiary Acquires Bangalore Hospital

Imperial Hospital and Research Centre Limited, Apollo Hospitals' subsidiary, completed acquisition of Belenus Champion Hospitals for Rs 1,650 million, expanding 125-bed facility to 175 beds.

10 Feb 2026

co actions results

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800